People: Hofseth Biocare ASA (HOFBC.OL)

HOFBC.OL on Oslo Stock Exchange

3.00NOK
3:40am EST
Price Change (% chg)

kr0.04 (+1.35%)
Prev Close
kr2.96
Open
kr3.20
Day's High
kr3.20
Day's Low
kr3.00
Volume
14,376
Avg. Vol
207,820
52-wk High
kr5.44
52-wk Low
kr2.51

Search Stocks

Summary

Name Age Since Current Position

Kjetil Olsen

54 2011 Independent Chairman of the Board

Jon Odegard

2013 Chief Executive Officer

Oystein Omvik

49 2013 Chief Financial Officer

Bomi Framroze

53 2010 Chief Scientific Officer

Matt Mixter

Director of Business Development

Tim Avila

Business Development Manager

Anders Bjornerem

36 2013 QA/QC Manager

Oddvar Myrmo

49 2012 Plant Manager Berkak

Roald Rogne

44 2012 Plant Manager Midsund

Henriette Godo Heggdal

33 2013 Director

Roger Hofseth

40 2011 Director

Marit Liland Sandvold

56 2013 Independent Director

Bjorn Tunheim

68 2012 Independent Director

Biographies

Name Description

Kjetil Olsen

Mr. Kjetil Olsen has served as Independent Chairman of the Board of Directors of Hofseth BioCare ASA since 2011. Mr. Olsen has previously held the position as Senior Vice President Supply Chain in Pronova BioPharma ASA and Managing Director of Pronova BioPharma Danmark A/S. Before joining Pronova BioPharma in 2001, Mr. Olsen held several manager positions within Norsk Hydro’s Engineering Division, Magnesium Division and Fertilizer Division. Mr. Olsen currently serves as Chief Operating Officer of Kebony ASA. Mr. Olsen holds a Master of Science in process engineering from the Norwegian University of Science and Technology. Mr. Olsen currently holds directorships, supervisory or senior management positions (other than positions in the Company and/or its subsidiaries) in Kebony as CO, SINTEF as Alternate Director of the Board and Trols AS as CEO and Chairman. Furthermore, Mr. Olsen has previously held directorships, supervisory or senior management positions during the last five years (other than positions in the Company and/or its subsidiaries) at Pronova BioPharma ASA as SVP Supply Chain, Pronova BioPharma Danmark A/S as Managing Director.

Jon Odegard

Mr. Jon Olav Odegard has been appointed Chief Executive Officer of Hofseth BioCare ASA effective from March 1, 2013. Before HBC, he had the position as managing director of Factoring in the SpareBank 1 Group, where he was responsible for strategy and business development, compliance and risk management among other things. Further, Odegard has worked as an adviser specialized in process and efficiency improvement in a number of industries. Mr. Odegard holds a MBA from Norwegian School of Management.

Oystein Omvik

Mr. Oystein Omvik has been appointed Chief Financial Officer (CFO) of Hofseth Biocare ASA effective from March 1, 2013. Mr. Omvik comes from the position as Senior Management Consultant at Gagn Consulting AS. He has held finance management positions within a various line of businesses. Oystein Omvik studied Business and Administration with specialization in Budgeting, Accounting & Tax at Norwegian School of Management.

Bomi Framroze

Dr. Bomi Framroze has served as Chief Scientific Officer of Hofseth Biocare ASA since 2010. Dr. Framroze is a Discovery scientist with over 40 worldwide patents and publications in Life Science and Chemical software research. He has been an Associate Director of Chemical Discovery at American Cyanamid, an Executive Director at Gharda Chemicals Ltd. and was Founder/CSO of Row2Technologies Inc. Since 2004 he has been carrying out Discovery research in process technologies, biochemistry and marine ingredients.

Matt Mixter

Mr. Matt Mixter serves as Director of Business Development at HOFSETH BIOCARE ASA. Matt is the managing director of US office based in Chicago, IL. He is responsible for developing and executing the strategy and positioning of HBC products in the US market. With almost a decade of diverse experience in the seafood industry and over 5 years of dealing with sister company Hofseth International, Matt brings a wealth of knowledge and proven success to the HBC organization.

Tim Avila

Anders Bjornerem

Mr. Anders Bjornerem has been QA/QC Manager at HOFSETH BIOCARE ASA since February 15, 2013. Anders holds a masters degree in environmental chemistry from the University of Bergen in cooperation with the National institute of Nutrition and Seafood research (NIFES). In the latest years he have worked in the food ingredients industry, in various positions covering quality, regulatory, product development and sales.

Oddvar Myrmo

Mr. Oddvar Myrmo has served as Plant Manager Berkak of Hofseth Biocare ASA since December 2012. Until then, he worked at the factory in Berkak for the last 5 years. He has nearly 20 years experience from food technology. Mr. Myrmo has long experience as Production Manager in the Norwegian Dairy Industry. He also has experience from Quality Management in Food Industry. Myrmo received his education at HiST, Trondheim. Former employment at TINE SA as Production Manager and Nortura as Production Manager.

Roald Rogne

Mr. Roald Rogne has served as Plant Manager Midsund of Hofseth Biocare ASA since January 2012. He has more than 20 years of experience from the fishing gear production (MoreNot AS) and the fishing production industry. He has held positions as Quality Manager, Project Manager and Production Planner. He was HS&E Manager of Firmenich Bjorge Biomarine.

Henriette Godo Heggdal

Ms. Henriette Godo Heggdal has been Director of HOFSETH BIOCARE ASA since December 27, 2013. She is Laboratory leader in Hofseth BioCare. She has served at Hofseth Biocare ASA as Laboratory leader/ Quality leader since 2010; Molde hospital as department for Medical Biochemistry (May 2010 - December 2010), Green Earth Industries as Laboratory leader/ Quality leader (April 2008 - April 2009), Molde hospital at department for Medical Biochemistry (December 2006 - April 2008), Molde hospital at department for Medical Biochemistry (Temp.) (May 2003 - October 2005), Children’s Allergy program in Trondheim NTNU - part-time (September 2003 - June 2004). She is Bioengineer (authorization) from Hogskolen i Sor Trondelag as Bioengineer (2001-2004).

Roger Hofseth

Mr. Roger Hofseth has served as Director of Hofseth Biocare ASA since October 2011 and from incorporation of the Company in 2009 until June 2010. In 2001, he incorporated Hofseth Invest AS, which represented the beginning for the Hofseth group. He has 20 years of experience in the fishery and food industry. His experience includes the founding of a number of companies and holding the position as Member of the Board and/or Management position in a number of companies within the fishery, fish farming and ecological food industry. He currently holds directorships, supervisory or management positions (other than positions in the Company and/or its subsidiaries) as Chairman of Norsk Fisketerminal AS, Chairman of Roger Hofseth AS, Chairman of Tyco Invest AS, Board Member of Syvde Eiendom AS, Board Member of Hofseth AS, CEO of Hofseth International, Board Member of Hofseth International AS and Board member of Seafood Farmers of Norway AS. He is also Board Member of Vanylven Vekst HF.

Marit Liland Sandvold

Ms. Marit Liland Sandvold has been Independent Director at HOFSETH BIOCARE ASA snce December 27, 2013. Ms. Liland Sandvold has more than 20 years of experience as a scientist in or manager in Applied Industrial Research and Development related to chemical industry, in particular pharmaceutical industry. She holds Doctorate in Philosophy (Dr.ing), Norwegian University of Science and Technology (1988) and Master of Science in Biophysics, Norwegian University of Science and Technology (1982). She was previsouly Vice President Preclinical R&D, Clavis Pharma AS, Norway (2001 - July 1, 2013), Department Manager and Principal Scientist, Department for Biotechnology, Norsk Hydro Research Centre, Porsgrunn, Norway (1997-2001), Principal Scientist, Department for Biotechnology, Norsk Hydro (1990-1997), (Hydro) Research Centre, Porsgrunn, Norway; Fixed term lecturer, Biophysics at Norwegian University of Science and Technology, (1988); PhD student at the Norwegian University of Science and Technology (1983-1988); Scientist at SINTEF, Toxicology, Dept. 21, Trondheim, Norway (1982) and Trainee, Institute of Toxicology, ETH, Zurich, Switzerland (1982).

Bjorn Tunheim

Mr. Bjorn Tunheim has been appointed as Independent Member of the Board of Directors of Hofseth Biocare ASA on May 24, 2012. Mr. Tunheims has previously worked as Director of SND More og Romsdal and Director of Innovasjon Norge (IN) More og Romsdal from the beginning to the retirement. He retired from May 1, 2012, after about 40 years in business development service. He had exciting internal tasks beyond his job as president, for example, member in SND's and IN's main credit committee for 6 years. He participated in the steering committee for the development of SOPP (Lotus-based case management system SND) and routine development for the entire. He previously worked at Innovasjon Norge (More and Romsdal) (Director) from 2003 to 2012, at Statens naerings- og distriktsutviklingsfond (SND) M & R (chair) (1993-2003), at Industribanken (IB) north country (officer / director) from 1987 to 1993, Statens Teknologiske Institutt avd. Nordvestlandet (STI) as advisor (1976-1987), at Fortifikasjon AS (private consulting firm working in Oslo and Vadso) (1975-1976), at Regional Development Fund, in Oslo (executive officer) (1971-1975). His education includes NVF's Leadership in transition, duration of 18 months (1996-1997), BI civil economy study period (1968-1972), Volda Economic Gymnasium (1964-1967). Mr. Tunheim has been a chairman of Geiranger Skysslag AS for 8 years, and in Geiranger Fjordservice AS for about 15 years. He is a co-owner and chairman of Olga Godo AS (fish processing / property rental) and KristianTun LTD (land development Company).

Basic Compensation

Name Fiscal Year Total

Kjetil Olsen

441,000

Jon Odegard

1,284,000

Oystein Omvik

1,162,000

Bomi Framroze

--

Matt Mixter

--

Tim Avila

--

Anders Bjornerem

724,000

Oddvar Myrmo

630,000

Roald Rogne

999,000

Henriette Godo Heggdal

--

Roger Hofseth

--

Marit Liland Sandvold

--

Bjorn Tunheim

68,000
As Of 30 Dec 2013
Search Stocks